Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan.
| Revenue (Most Recent Fiscal Year) | $3.34B |
| Net Income (Most Recent Fiscal Year) | $354.21M |
| PE Ratio (Current Year Earnings Estimate) | 26.38 |
| PE Ratio (Trailing 12 Months) | 30.14 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 3.18 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.47 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 17.42 |
| Pre-Tax Margin (Trailing 12 Months) | 15.57% |
| Net Margin (Trailing 12 Months) | 10.56% |
| Return on Equity (Trailing 12 Months) | 11.81% |
| Return on Assets (Trailing 12 Months) | 8.38% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.97 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.30 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.12 |
| Inventory Turnover (Trailing 12 Months) | 2.77 |
| Book Value per Share (Most Recent Fiscal Quarter) | $4.87 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.12 |
| Earnings per Share (Most Recent Fiscal Year) | $0.57 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.56 |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 629.48M |
| Free Float | -- |
| Market Capitalization | $10.63B |
| Average Volume (Last 20 Days) | 0.13M |
| Beta (Past 60 Months) | 1.14 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.16 |
| Dividend Yield (Based on Last Quarter) | 0.94% |